3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG)
Articles > Article · 2026
Authors: B. Dursun, S. Yaslikaya, S. Sekmek, T. Önder, H.C. Yildirim, O. Acar, N. Sever, S. Gokcek, S. Ön, F. Aslan, G.S.Y. Keskin, Z. Sucuoglu Isleyen, G. Savas, M.E. Kalender, O. Bal, U.Y. Arslan, M. Sahbazlar, B. Cakar, H.M. Türk, H. Akbulut
ESMO Open, International, WoS, 2026, vol 11, pp 106106-106106
DOI: 10.1016/j.esmoop.2026.106106
Summary
Achieving no evidence of disease (NED) in HER2-positive metastatic breast cancer (MBC) has been proposed as a surrogate for durable disease control. However, its clinical significance and predictive factors are not yet well established.